These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Somatostatin, somatostatin analogues and other vasoactive drugs in the treatment of bleeding oesophageal varices. de Franchis R Dig Liver Dis; 2004 Feb; 36 Suppl 1():S93-100. PubMed ID: 15077917 [TBL] [Abstract][Full Text] [Related]
8. Approach to the management of bleeding esophageal varices: role of somatostatin. Avgerinos A Digestion; 1998; 59 Suppl 1():1-22. PubMed ID: 9603441 [TBL] [Abstract][Full Text] [Related]
9. [Emergency medical treatment of portal hypertension]. Heresbach D; Bretagne JF; Gosselin M Presse Med; 1995 Sep; 24(28):1311-4. PubMed ID: 7501625 [TBL] [Abstract][Full Text] [Related]
10. Somatostatin or octreotide for acute bleeding oesophageal varices. Gotzsche PC Cochrane Database Syst Rev; 2000; (2):CD000193. PubMed ID: 10796699 [TBL] [Abstract][Full Text] [Related]
11. Role of vasoactive drugs in the treatment of bleeding oesophageal varices. Goulis J; Burroughs AK Digestion; 1999; 60 Suppl 3():25-34. PubMed ID: 10567786 [TBL] [Abstract][Full Text] [Related]
12. Medical management of variceal bleeding in patients with cirrhosis. Abraldes JG; Dell'Era A; Bosch J Can J Gastroenterol; 2004 Feb; 18(2):109-13. PubMed ID: 14997222 [TBL] [Abstract][Full Text] [Related]
15. Lack of difference among terlipressin, somatostatin, and octreotide in the control of acute gastroesophageal variceal hemorrhage. Seo YS; Park SY; Kim MY; Kim JH; Park JY; Yim HJ; Jang BK; Kim HS; Hahn T; Kim BI; Heo J; An H; Tak WY; Baik SK; Han KH; Hwang JS; Park SH; Cho M; Um SH Hepatology; 2014 Sep; 60(3):954-63. PubMed ID: 24415445 [TBL] [Abstract][Full Text] [Related]
16. [Drug therapy of hemorrhage in esophageal and gastric varices: role of vasoactive drugs]. Pulanić R Lijec Vjesn; 2000; 122(11-12):276-83. PubMed ID: 11291271 [TBL] [Abstract][Full Text] [Related]
17. Vasoactive Agents for the Management of Variceal Bleeding: A Mixed Treatment Comparison Network Meta-analysis and Trial Sequential Analysis of Randomized Clinical Trials. Sridharan K; Sivaramakrishnan G Drug Res (Stuttg); 2019 Sep; 69(9):487-495. PubMed ID: 30776840 [TBL] [Abstract][Full Text] [Related]
18. Sclerotherapy plus octreotide versus sclerotherapy alone in the management of gastro-oesophageal variceal hemorrhage. Shah HA; Mumtaz K; Jafri W; Abid S; Hamid S; Ahmad A; Abbas Z J Ayub Med Coll Abbottabad; 2005; 17(1):10-4. PubMed ID: 15929518 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of vasopressin/terlipressin and somatostatin/octreotide for the prevention of early variceal rebleeding after the initial control of bleeding: a systematic review and meta-analysis. Wang C; Han J; Xiao L; Jin CE; Li DJ; Yang Z Hepatol Int; 2015 Jan; 9(1):120-9. PubMed ID: 25788386 [TBL] [Abstract][Full Text] [Related]
20. No mortality difference following treatment with terlipressin or somatostatin in cirrhotic patients with gastric variceal hemorrhage. Hung TH; Tsai CC; TsenK GC; Hsieh YH; Tseng CW Saudi J Gastroenterol; 2016; 22(3):220-5. PubMed ID: 27184641 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]